The precautionary principle and biotechnology
by Julian Morris
International Journal of Biotechnology (IJBT), Vol. 4, No. 1, 2002

Abstract: Risk is ubiquitous and not necessarily bad. Risk management means balancing risks and benefits, or balancing risks one against another. Well-characterised catastrophic risks should be avoided. Poorly characterised potential catastrophes should be approached differently. Uncertainty must not be equated with risk. Decisions regarding the development and marketing of new technologies take place within a complex web of formal and informal institutions. To this, some groups have been attempting to add the ''precautionary principle'' (PP). However, the PP is not an appropriate tool for decision making under uncertainty. Application of the PP would actually create uncertainty and thereby undermine attempts to reduce risks; it would slow down economic growth and harm especially the poorest people in society. Applying the PP to biotechnology would lead to arbitrary - rather than scientifically justifiable - restrictions on the use of this most beneficial technology.

Online publication date: Sun, 13-Jul-2003

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com